MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceutical Drug Discovery & Development (Miscellaneous)
Tesaro (NASDAQ: TSRO)
Organization & Developments: Tesaro
Parents
2013: The $100M Club: Where the Major League Life Sciences Companies Are (2013)
Tesaro (NASDAQ: TSRO)
Children
2011: Blog Archive » TESARO In-Licenses ALK Program from Amgen (2011)
2011: Blog Archive » TESARO In-Licenses Rolapitant from OPKO (2011)
2011: Tesaro’s business model is focused on acquiring, developing and commercializing cancer drug candidates (2011)
2014: Tesaro stock soars after entering immuno-oncology field
2016: Biotech Forum Daily Digest: Tesaro's Huge Week! Brexit Losses Gone, Spotlight On Applied Genetics Technologies
2017: Manufacturing Issues Stall Tesaro Cancer Nausea Drug at FDA
2017: Tesaro Dives On 'Sticker Shock' For $177,000 Drug
2018: Tesaro: Oncology Concern Seeing Big Insider Buying - Tesaro (NASDAQ:TSRO)
Jumps
*Key People: Tesaro
Finance & Acquisitions: Tesaro